Latest filing published 05 Apr 2022 for GoodRx Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Andrew Slutsky, listed as chief executive, appears in our data through filings on GoodRx Holdings, Inc. shares, published by SEC (Form 4). Between 24 May 2021 and 1 April 2022, the trades on record add up to 15 filings.
On the market, this insider has only sold: 10 sales, €3.7M in total. Other entries cover 5 option exercises.
On 5 April 2022 came the latest disclosure, an option exercise in GoodRx Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations